Lowering Lp(a) potently and safely with antisense technology
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- AHA 2018Unexpectedly large CV benefit with icosapent ethyl in statin-treated patients at high CV risk
Prof. Erik Stroes, MD
Deepak Bhatt, MD
Eric Velazquez, MD